Mitral Regurgitation

Current Problems in Cardiology

Volumn 34, Issue 3, 2009, Pages 93-136

  Ahmed, Mustafa I ^a   McGiffin, David C ^a   O'Rourke, Robert A ^a   Dell'Italia, Louis J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROHORMONE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ANTICOAGULANT THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; RHEUMATIC DISEASE; THORAX RADIOGRAPHY; TREATMENT INDICATION;

CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR AGENTS; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; DISEASE PROGRESSION; HEMODYNAMICS; HUMANS; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION;

EID: 59949093808     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2008.11.002     Document Type: Article

References (191)

1. Perloff J.K., and Roberts W.C. The mitral apparatus: functional anatomy of mitral regurgitation. Circulation 46 (1972) 227-239
2. Anderson R.H., and Wilcox B.R. The anatomy of the mitral valve. In: Wells F.C., and Shapiro L.M. (Eds). Mitral Valve Disease (1996), Butterworth-Heinemann, Oxford, England 4
3. Ormiston J.A., Shah P.M., Tei C., et al. Size and motion of the mitral valve annulus in man. I. A two-dimensional echocardiographic method and findings in normal subjects. Circulation 64 (1981) 113
4. Davis P.K.B., and Kinmouth J.B. The movements of the annulus of the mitral valve. J Cardiovasc Surg (1963) 427-431
5. Kodavatiganti R. Intraoperative assessment of the mitral valve by transesophageal echocardiography: An overview. Ann Cardiol Anaesth 5 2 (2002) 127-134
6. Rushmer R., Finlayson B., and Nash A. Movements of the mitral valve. Circul Res 4 (1956) 337
7. Carpentier A. Cardiac valve surgery-the "French correction". J Thorac Cardiovasc Surg 86 3 (1983) 323-337
8. Bonow R.O., Carabello B.A., Chatterjee K., et al. ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 48 (2006) 1-148
9. Lam J.H.C., Ranganathan N., Wigle E.D., et al. Morphology of the human mitral valve I chordae Tendineae: a new classification. Circulation 41 (1970) 449
10. Condado J.A., and Velez-Gimon M. Catheter-based approach to mitral regurgitation. J Interv Cardiol 16 6 (2003) 523-534
11. Voci P., Bilotta F., Caretta Q., et al. Papillary muscle perfusion pattern. A hypothesis for ischemic papillary muscle dysfunction. Circulation 91 6 (1995) 1714-1718
12. Tanimoto M., and Pai R.G. Effect of isolated left atrial enlargement on mitral annular size and valve competence. Am J Cardiol 77 9 (1996) 769-774
13. Iung B., Baron G., Butchart E.G., et al. A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease. Eur Heart J 24 (2003) 1231-1243
14. Rosen S.E., Borer J.S., Hochreiter C., et al. Natural history of the asymptomatic patients with severe mitral regurgitation secondary to mitral valve prolapse and with normal left and right ventricular function. Am J Cardiol 74 (1994) 374-380
15. Carpentier A., Chauvaud S., Fabiani J., et al. Reconstructive surgery of mitral valve incompetence: ten year appraisal. J Thorac Cardiovasc Surg 79 (1980) 338
16. Marzo K.P., and Herling I.M. Valvular disease in the elderly. Cardiovasc Clin 23 (1993) 175
17. Carpentier A.F., Pellerin M., Fuzellier J.F., and Relland J.Y. Extensive calcification of the mitral valve annulus: pathology and surgical management. J Thorac Cardiovasc Surg 111 4 (1996) 718-729
18. Olson L.J., Subramanian R., Ackermann D.M., et al. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc 62 1 (1987) 22-34
19. Tamura K., Fukuda Y., Ishizaki M., et al. Abnormalities in elastic fibers and other connective-tissue components of floppy mitral valve. Am Heart J 129 6 (1995) 1149-1158
20. Rabkin E., Aikawa M., Stone J.R., et al. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 104 21 (2001) 2525-2532
21. Avierinos J.F., Gersh B.J., Melton III L.J., et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation 106 11 (2002) 1355-1361
22. Nesta F., Leyne M., Yosefy C., et al. New locus for autosomal dominant mitral valve prolapse on chromosome 13: clinical insights from genetic studies. Circulation 112 13 (2005) 2022-2030
23. Freed L.A., Acierno Jr. J.S., Dai D., et al. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet 72 6 (2003) 1551-1559
24. Disse S., Abergel E., Berrebi A., et al. Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet 65 5 (1999) 1242-1251
25. Roberts R. Another chromosomal locus for mitral valve prolapse: close but no cigar. Circulation 112 13 (2005) 1924-1926
26. Ng C.M., Cheng A., Myers L.A., et al. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 114 11 (2004) 1586-1592
27. Weyman A.E., and Scherrer-Crosbie M. Marfan syndrome and mitral valve prolapse. J Clin Invest 114 11 (2004) 1543-1546
28. Grande-Allen K.J., Griffin B.P., Ratliff N.B., et al. Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations. J Am Coll Cardiol 42 2 (2003) 271-277
29. Grande-Allen K.J., Borowski A.G., Troughton R.W., et al. Apparently normal mitral valves in patients with heart failure demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study. J Am Coll Cardiol 45 1 (2005) 54-61
30. O'Brien K.D., and Fishbein D.P. Mitral valve abnormalities in congestive heart failure: an interplay between form and function?. J Am Coll Cardiol 45 1 (2005) 62-64
31. Barber J.E., Kasper F.K., Ratliff N.B., et al. Mechanical properties of myxomatous mitral valves. J Thorac Cardiovasc Surg 122 5 (2001) 955-962
32. Barber J.E., Ratliff N.B., Cosgrove III D.M., et al. Myxomatous mitral valve chordae. I: Mechanical properties. J Heart Valve Dis 10 3 (2001) 320-324
33. Glesby M.J., and Pyeritz R.E. Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum. JAMA 262 4 (1989) 523-528
34. Flameng W., Herijgers P., and Bogaerts K. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation 107 12 (2003) 1609-1613
35. Van der Meer J.T.M., Thompson J., Valkenburg H.A., and Michel M.F. Epidemiology of bacterial endocarditis in the Netherlands. Arch Intern Med 152 (1992) 1863-1868
36. Wallace S.M., Walton B.I., Kharbanda R.K., et al. Mortality from infective endocarditis: clinical predictors of outcome. Heart 88 (2002) 53-60
37. Verheul H.A., van den Brink R.B., van Vreeland T., et al. Management of active infective endocarditis and outcome in a 25-year period. Am J Cardiol 72 (1993) 682-687
38. Croft C.H., Woodward W., Elliot A.P.J., et al. Analysis of medical versus surgical therapy in active complicated native valve endocarditis. Am J Cardiol 51 (1983) 1650-1655
39. Horstkotte D., Fillet F., Gutschik E., et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 25 3 (2004) 267-276
40. Doukas G., Oc M., Alexiou C., et al. Mitral valve repair for active culture positive infective endocarditis. Heart 92 3 (2006) 361-363
41. Zegdi R., Debaucher M., Latremouille C., et al. Long-term results of mitral valve repair in active endocarditis. Circulation 111 19 (2005) 2532-2536
42. Livesey S.A. Mitral valve reconstruction in the presence of infection. Heart 92 3 (2006) 289-290
43. Sternik L., Zehr K.J., Orszulak T.A., et al. The advantage of repair of mitral valve in acute endocarditis. J Heart Valve Dis 11 (2002) 91-98
44. de Kerchove L., Vanoverschelde J.L., Poncelet A., et al. Reconstructive surgery in active mitral valve endocarditis: feasibility, safety and durability. Eur J Cardiothorac Surg 31 (2007) 592-599
45. Kumar A.S., Talwar S., Saxena A., et al. Results of mitral valve repair in rheumatic mitral regurgitation. Interact Cardiovasc Thorac Surg 5 (2006) 356-361
46. Hanson T.P., Edwards B.S., and Edwards J.E. Pathology of surgically excised mitral valves: one hundred consecutive cases. Arch Pathol Lab Med 109 (1985) 823
47. Waller B.F., Howard J., and Fess S. Pathology of mitral valve stenosis and pure mitral regurgitation. Part I. Clin Cardiol 17 (1994) 330
48. Grigioni F., Enriquez-Sarano M., Ling L.H., et al. Sudden death in mitral regurgitation due to flail leaflet. J Am Coll Cardiol 34 7 (1999) 2078-2085
49. Rosenhek R., Rader F., Klaar U., et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 113 18 (2006) 2238-2244
50. Ling L.H., Enriquez-Sarano M., Seward J.B., et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 335 19 (1996) 1417-1423
51. Duren D.R., Becker A.E., and Dunning A.J. Long-term follow-up of idiopathic mitral valve prolapse in 300 patients: a prospective study. J Am Coll Cardiol 11 (1988) 42-47
52. Tribouilloy C.M., Enriquez-Sarano M., Schaff H.V., et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation rationale for optimizing surgical indications. Circulation 99 (1999) 400-405
53. Schwammenthal E., Chen C., Benning F., et al. Dynamics of mitral regurgitant flow and orifice area. Physiologic application of the proximal flow convergence method: clinical data and experimental testing. Circulation 90 1 (1994) 307-322
54. Enriquez-Sarano M., Sinak L.J., Tajik A.J., et al. Changes in effective regurgitant orifice throughout systole in patients with mitral valve prolapse. A clinical study using the proximal isovelocity surface area method. Circulation 92 10 (1995) 2951-2958
55. Yiu S.F., Enriquez-Sarano M., Tribouilloy C., et al. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation 102 12 (2000) 1400-1406
56. Gaasch W.H., and Aurigemma G.P. Inhibition of the renin-angiotensin system and the left ventricular adaptation to mitral regurgitation. J Am Coll Cardiol 39 8 (2002) 1380-1383
57. Borer J.S., and Bonow R.O. Contemporary approach to aortic and mitral regurgitation. Circulation 108 20 (2003) 2432-2438
58. Wisenbaugh T., Spann J.F., and Carabello B.A. Differences in myocardial performance and load between patients with similar amounts of chronic aortic versus chronic mitral regurgitation. J Am Coll Cardiol 3 4 (1984) 916-923
59. Grose R., Strain J., and Cohen M.V. Pulmonary arterial V waves in mitral regurgitation: clinical and experimental observations. Circulation 69 2 (1984) 214-222
60. Braunwald E., and Awe W.C. The syndrome of severe mitral regurgitation with normal left atrial pressure. Circulation 27 (1963) 29-35
61. Lapu-Bula R., Robert A., Van Craeynest D., et al. Contribution of exercise-induced mitral regurgitation to exercise stroke volume and exercise capacity in patients with left ventricular systolic dysfunction. Circulation 106 11 (2002) 1342-1348
62. Hochreiter C., Niles N., Devereux R.B., et al. Mitral regurgitation: Relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients. Circulation 73 5 (1986) 900-912
63. Dini F.L., Conti U., Fontanive P., et al. Right ventricular dysfunction is a major predictor of outcome in patients with moderate to severe mitral regurgitation and left ventricular dysfunction. Am Heart J 154 1 (2007) 172-179
64. Carabello B.A., Zile M.R., Tanaka R., et al. Left ventricular hypertrophy due to volume versus pressure overload. Am J Physiol 263 (1992) H1137-H1444
65. Conway M.A., Bottomley P.A., Ouwerkerk R., et al. Mitral regurgitation: Impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. Circulation 97 17 (1998) 1716-1723
66. Corin W.J., Murakami T., Monrad E.S., et al. Left ventricular passive diastolic properties in chronic mitral regurgitation. Circulation 83 3 (1991) 797-807
67. Goldfine S.M., Pena M., Magid N.M., et al. Myocardial collagen in cardiac hypertrophy resulting from chronic aortic regurgitation. Am J Ther 5 3 (1998) 139-146
68. Grossman W. Cardiac hypertrophy: Useful adaptation or pathologic process?. Am J Med 69 4 (1980) 575-584
69. Ryan T.D., Rothstein E., Aban I., et al. Left ventricular remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 49 (2007) 811-821
70. Chandrashakhar Y. Embracing the diversity of left ventricular remodeling. J Am Coll Cardiol 49 (2007) 822-825
71. LeGrice I.J., Smaill B.H., Chai L.Z., et al. Laminar structure of the heart: ventricular myocyte arrangement and connective tissue architecture in the dog. Am J Physiol 269 (1995) H571-H582
72. Stewart J.A., Wei C.-C., Brower G.L., et al. Cardiac mast cell and chymase mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog. J Mol Cell Cardiol 35 (2003) 311-319
73. Dell'Italia L.J., Meng Q.C., Balcells E., et al. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation. Am J Physiol 269 6 Pt. 2 (1995) H2065-H2073
74. Dell'Italia L.J., Balcells E., Meng Q.C., et al. Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogs. Am J Physiol 273 (1997) H961-H970
75. Perry G.J., Wei C.C., Su X., et al. Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog. J Am Coll Cardiol 39 (2002) 1374-1379
76. Brickner M.E., and Starling M.R. Dissociation of end systole from end ejection in patients with long-term mitral regurgitation. Circulation 81 4 (1990) 1277-1286
77. Starling M.R., Kirsh M.M., Montgomery D.G., et al. Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction. J Am Coll Cardiol 22 1 (1993) 239-250
78. Carabello B.A., Nolan S.P., and McGuire L.B. Assessment of preoperative left ventricular function in patients with mitral regurgitation: value of the end-systolic wall stress-end-systolic volume ratio. Circulation 64 6 (1981) 1212-1217
79. Carabello B.A., and Spann J.F. The uses and limitations of end-systolic indexes of left ventricular function. Circulation 69 5 (1984) 1058-1064
80. Mehta R.H., Supiano M.A., Oral H., et al. Compared with control subjects, the systemic sympathetic nervous system is activated in patients with mitral regurgitation. Am Heart J 145 6 (2003) 1078-1085
81. Sakagoshi N., Nakano S., Taniguchi K., et al. Relation between myocardial beta-adrenergic receptor and left ventricular function in patients with left ventricular volume overload due to chronic mitral regurgitation with or without aortic regurgitation. Am J Cardiol 68 1 (1991) 81-84
82. Detaint D., Messika-Zeitoun D., Avierinos J.F., et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 111 18 (2005) 2391-2397
83. Sutton T.M., Stewart R.A., Gerber I.L., West T.M., Richards A.M., Yandle T.G., and Kerr A.J. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 41 12 (2003) 2280-2287
84. Oral H., Sivasubramanian N., Dyke D.B., et al. Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with chronic mitral regurgitation. Circulation 107 6 (2003) 831-837
85. Leszek P., Korewicki J., Klisiewicz A., et al. Reduced myocardial expression of calcium handling protein in patients with severe chronic mitral regurgitation. Eur J Cardiothorac Surg 30 5 (2006) 737-743
86. Pierard L.A., and Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 351 16 (2004) 1627-1634
87. Zipes L., and Bonow B. Valvular heart disease. Braunwald's heart disease: a textbook of cardiovascular. (ed 7) (2005), Medicine Elsevier Saunders 1568-1570
88. Folland E., Kriegel B., Henderson W., et al. Implications of third heart sounds in patients with valvular heart disease: the Veterans Affairs cooperative study on valvular heart disease. N Engl J Med 327 (1992) 458-462
89. Desjardins V., Enriquez-Sarano M., Tajik A., et al. Intensity of murmurs correlates with severity of valvular regurgitation. Am J Med 100 (1996) 149-156
90. Lembo N., Dell'italia L.J., Crawford M.H., et al. Bedside diagnosis of systolic murmurs. N Engl J Med 318 24 (1988) 1572-1578
91. Goldstein M.A., Michelson E.L., and Dreifus L.S. The electrocardiogram in valvular heart disease. Cardiovasc Clin 23 (1993) 55
92. Ross R.S., and Criley J.M. Contrast radiography in mitral regurgitation. Prog Cardiovasc Dis 5 (1962) 195
93. Hurst J.W. Memories of patients with a giant left atrium. Circulation 104 22 (2001) 2630-2631
94. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (ACC/AHA/ASE Committee to Update the 1997 guidelines for the clinical application of echocardiography). J Am Coll Cardiol 42 (2003) 954-970
95. Carpentier A. Cardiac valve surgery-the "French correction". J Thorac Cardiovasc Surg 86 (1983) 323-337
96. Enriquez-Sarano M., Freeman W.K., Tribouilloy C.M., et al. Functional anatomy of mitral regurgitation: accuracy and outcome implications of TEE. J Am Coll Cardiol 34 (1999) 1129-1136
97. Otto C.M. Clinical practice. Evaluation and management of chronic mitral regurgitation. N Engl J Med 345 10 (2001) 740-746
98. Spain M.G., Smith M.D., Grayburn P.A., et al. Quantitative assessment of mitral regurgitation by Doppler color flow imaging: angiographic and hemodynamic correlations. J Am Coll Cardiol 13 3 (1989) 585-590
99. Hall S.A., Brickner M.E., Willett D.L., et al. Assessment of mitral regurgitation severity by Doppler color flow mapping of the vena contracta. Circulation 95 3 (1997) 636-642
100. Zoghbi W.A., Enriquez-Sarano M., Foster E., et al. American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 16 (2003) 777-802
101. Rivera M. Utility of the effective regurgitant orifice for the quantification of regurgitant valve lesions. Rev Esp Cardiol 59 10 (2006) 997-999
102. Monin J.-L., Dehant P., Roiron C., et al. Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes. J Am Coll Cardiol 46 (2005) 302-309
103. Shiran A., Merdler A., Ismir E., et al. Intraoperative transesophageal echocardiography using a quantitative dynamic loading test for the evaluation of ischemic mitral regurgitation. J Am Soc Echocardiogr 20 6 (2007) 690-697
104. Gisbert A., Souliere V., Denault A.Y., et al. Dynamic quantitative echocardiographic evaluation of mitral regurgitation in the operating department. J Am Soc Echocardiogr 19 2 (2006) 140-146
105. Lee R., Haluska B., Leung D.Y., et al. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart 91 (2005) 1407-1412
106. Fuchs R.M., Heuser R.R., Yin F.C., and Brinker J.A. Limitations of pulmonary wedge V waves in diagnosing mitral regurgitation. Am J Cardiol 49 (1982) 849-854
107. Hundley W.G., Li H.F., Willard J.E., et al. Magnetic resonance imaging assessment of the severity of mitral regurgitation. Circulation 92 (1995) 1151
108. Stork A., Franzen O., Ruschewski H., et al. Assessment of functional anatomy of the mitral valve in patients with mitral regurgitation with cine magnetic resonance imaging: comparison with transesophageal echocardiography and surgical results. (epub ahead of print). Eur Radiol (2007)
109. Wilson W., Taubert K.A., Gewitz M., et al. Prevention of infective endocarditis. Guidelines from the American Heart Association. Circulation 116 15 (2007) 1736-1754
110. Grayburn P.A. Vasodilator therapy for chronic aortic and mitral regurgitation. Am J Med Sci 320 (2000) 202-208
111. Harris K.M., Aeppli D.M., and Carey C.F. Effects of angiotensin-converting enzyme inhibition on mitral regurgitation severity, left ventricular size, and functional capacity. Am Heart J 150 5 (2005) 1106
112. Wisenbaugh T., Sinovich V., Dullabh A., et al. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 3 2 (1994) 197-204
113. Oh S.H., and Meyers D.G. Afterload reduction may halt and beta-adrenergic blockade may worsen progression of left ventricular dysfunction in patients with chronic compensated mitral regurgitation: a retrospective cohort study. Angiology 58 2 (2007) 196-202
114. Marcotte F., Honos G.N., Walling A.D., et al. Effect of angiotensin-converting enzyme inhibitor therapy in mitral regurgitation with normal left ventricular function. Can J Cardiol 13 5 (1997) 479-485
115. Nemoto S., Hamawaki M., DeFreitas G., et al. Differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation. J Am Coll Cardiol 40 1 (2002) 149-154
116. Tallaj J., Wei C.C., Hankes G.H., et al. B-1-adrenergic receptor blockade attenuates angiotensin II mediated catecholamine release into the cardiac interstitium in mitral regurgitation. Circulation 108 (2003) 225-230
117. Hankes G.H., Ardell J.L., Tallaj J., et al. Beta1-adrenoceptor blockade mitigates excessive norepinephrine release into cardiac interstitium in mitral regurgitation in dog. Am J Physiol Heart Circ Physiol 291 1 (2006) H147-H151
118. Tsutsui H., Spinale F.G., Nagatsu M., et al. Effects of chronic beta-adrenergic blockade on the left ventricular and cardiomyocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest 93 6 (1994) 2639-2648
119. Starling M.R. Is prophylactic beta-adrenergic blockade appropriate in mitral regurgitation: impact of cellular pathophysiology. Adv Cardiol 41 (2004) 25-35
120. Lee E.M., Shapiro L.M., and Wells F.C. Superiority of mitral valve repair in surgery for degenerative mitral regurgitation. Eur Heart J 18 (1997) 655-663
121. Enriquez Sarano M., Schaff H.V., Orszulak T.A., et al. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation 91 (1995) 1022-1028
122. Braunberger E., Deloche A., Berrebi A., et al. Very long-term results (more than 20 years) of valve repair with Carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation 104 (2001) I8-I11
123. Tischler M.D., Cooper K.A., Rowen M., et al. Mitral valve replacement versus mitral valve repair a Doppler and quantitative stress echocardiographic study. Circulation 89 (1994) 132-137
124. Otto C.M. Timing of surgery in mitral regurgitation. Heart 89 1 (2003) 100-105
125. Mohty D., Orszulak T.A., Schaff H.V., et al. Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation 104 (2001) 11-17
126. Gillinov A.M., and Cosgrove D.M. Mitral valve repair for degenerative disease. J Heart Valve Dis 11 (2002) S15-S20
127. Suri R.M., Schaff H.V., Dearani J.A., et al. Recurrent mitral regurgitation after repair: should the mitral valve be re-repaired?. J Thorac Cardiovasc Surg 132 6 (2006) 1390-1397
128. Vahanian A., Baumgartner H., Bax J., et al. Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. ESC Committee for Practice guidelines. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 28 2 (2007) 230-268
129. Rozich J.D., Carabello B.A., Usher B.W., et al. Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Mechanisms for differences in postoperative ejection performance. Circulation 86 (1992) 1718-1726
130. Enriquez-Sarano M., Schaff H.V., and Frye R.L. Mitral regurgitation: what causes the leakage is fundamental to the outcome of valve repair. Circulation 108 (2003) 253-256
131. Northrup III W.F. Mitral valve repair: We must do a better job. Curr Cardiol Rep 7 (2005) 94-100
132. Savage E.B., Ferguson Jr. T.B., and DiSesa V.J. Use of mitral valve repair: analysis of contemporary US experience reported to the Society of Thoracic Surgeons national cardiac database. Ann Thorac Surg 75 3 (2003) 820-825
133. Friedewald V.E., Bonow R.O., Borer J.S., et al. The Editor's Roundtable: cardiac valve surgery. Am J Cardiol 99 9 (2007) 1269-1278
134. Bridgewater B., Hooper T., Munsch C., et al. Mitral repair best practice: proposed standards. Heart 92 7 (2006) 939-944
135. Mirabel M., Iung B., Baron G., et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?. Eur Heart J 28 11 (2007) 1358-1365
136. Law A., and Chan K.L. Surgical referral in symptomatic mitral regurgitation: greater compliance with guidelines is needed. Eur Heart J 28 11 (2007) 1281-1282
137. Crawford M.H., Souchek J., Oprian C.A., et al. Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs cooperative study on valvular heart disease. Circulation 81 4 (1990) 1173-1181
138. Enriquez-Sarano M., Avierinos J.F., Messika-Zeitoun D., et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352 9 (2005) 875-883
139. Zile M.R., Gaasch W.H., Carroll J.D., et al. Chronic mitral regurgitation: predictive value of preoperative echocardiographic indexes of left ventricular function and wall stress. J Am Coll Cardiol 3 (1984) 235-242
140. Grigioni F., Avierinos J.F., Ling L.H., et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation determinants and long-term outcome. J Am Coll Cardiol 40 (2002) 84-92
141. Tanaka K., Ohtaki E., Matsumura T., et al. Impact of a preoperative mitral regurgitation scoring system on outcome of surgical repair for mitral valve prolapse. Am J Cardiol 92 11 (2003) 1306-1309
142. Matsumura T., Ohtaki E., Tanaka K., et al. Echocardiographic prediction of left ventricular dysfunction after mitral valve repair for mitral regurgitation as an indicator to decide the optimal timing of repair. J Am Coll Cardiol 42 3 (2003) 458-463
143. Enriquez-Sarano M., Tajik A.J., Schaff H.V., et al. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol 24 6 (1994) 1536-1543
144. Mehta R.H., Eagle K.A., Coombs L.P., et al. Influence of age on outcomes in patients undergoing mitral valve replacement. Ann Thorac Surg 74 5 (2002) 1459-1467
145. Ruel M., Kulik A., Lam B.K., et al. Long term outcomes of valve replacement with modern prostheses in young adults. Eur J Cardiothorac Surg 27 (2005) 425-433
146. DiGregorio V., Zehr K.J., Orszulak T.A., et al. Results of mitral surgery in octogenarians with isolated non-rheumatic mitral regurgitation. Ann Thorac Surg 78 (2004) 807-813
147. Nagendran J., Norris C., Maitland A., et al. Is mitral valve surgery safe in octogenarians?. Eur J Cardiothorac Surg 28 1 (2005) 83-87
148. Mack M.J. Percutaneous mitral valve repair: a fertile field of innovative treatment strategies. Circulation 113 19 (2006) 2269-2271
149. Vassiliades Jr. T.A., Block P.C., Cohn L.H., et al. Society of Thoracic Surgeons; American Association for Thoracic Surgery; Society for Cardiovascular Angiography and Interventions. The clinical development of percutaneous heart valve technology. J Thorac Cardiovasc Surg 129 5 (2005) 970-976
150. Palacios I.F., Condado J.A., Brandi S., et al. Safety and feasibility of acute percutaneous septal sinus shortening: first-in-human experience. Cathet Cardiovasc Interv 69 4 (2007) 513-518
151. Maisano F., Torracca L., Oppizzi M., et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg 13 3 (1998) 240-245
152. EVEREST Registry. Significant reduction in mitral regurgitation 12 months following percutaneous mitral valve repair: initial experience with the MitraClip device. Clin Cardiol 30 8 (2007) 419
153. Fuster V., Ryden L.E., Cannom D.S., et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC, Guidelines for the Management of Patients with Atrial Fibrillation, 2006 114 7 (2006) e257-e354
154. Lim E., Barlow C.W., Hosseinpour A.R., et al. Influence of atrial fibrillation on outcome following mitral valve repair. circulation 104 (2001) I59-I63
155. Eguchi K., Ohtaki E., Matsumura T., et al. Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation. Eur Heart J 26 (2005) 1866-1872
156. Ngaage D.L., Schaff H.V., Mullany C.J., et al. Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified?. Ann Thorac Surg 84 2 (2007) 434-442
157. Alexiou C., Doukas G., Oc M., et al. The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation. Eur J Cardiothorac Surg 31 4 (2007) 586-591
158. Betriu A., Chaitman B.R., and Almazan A. Preoperative determinants of return to sinus rhythm after valve replacement. In: Cohn L.H., and Gallucci V. (Eds). Cardiac Bioprosthesis (1982), Yorke Medical Books, New York, NY 184-191
159. Chua Y.L., Schaff H.V., Orszulak T.A., et al. Outcome of mitral valve repair in patients with preoperative atrial fibrillation should the maze procedure be combined with mitral valvuloplasty?. J Thorac Cardiovasc Surg 107 (1994) 408-415
160. Raanani E., Albage A., David T.E., et al. The efficacy of the Cox/maze procedure combined with mitral valve surgery a matched control study. Eur J Cardiothorac Surg 19 (2001) 438-442
161. Nieminen M.S., Bohm M., Cowie M.R., et al. ESC Committee for Practice. Guideline (CpG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
162. Goldman A.P., Glover M.U., Mick W., et al. Role of echocardiography/Doppler in cardiogenic shock: silent mitral regurgitation. Ann Thorac Surg 52 2 (1991) 296-299
163. Madu E.C., and D'cruz I.A. The vital role of papillary muscles in mitral and ventricular function: echocardiographic insights. Clin Cardiol 20 2 (1997) 93-98
164. Castello R., Fagan Jr. L., Lenzen P., et al. Comparison of transthoracic and transesophageal echocardiography for assessment of left-sided valvular regurgitation. Am J Cardiol 68 17 (1991) 1677-1680
165. Yoran C., Yellin E.L., Becker R.M., et al. Mechanism of reduction of mitral regurgitation with vasodilator therapy. Am J Cardiol 43 (1979) 773-777
166. Chatterjee K., Parmley W.W., Swan H.J., et al. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus. Circulation 48 (1973) 684-690
167. Trichon B.H., Felker G.M., Shaw L.K., et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 91 (2003) 538-543
168. Breithardt O.A., Sinha A.M., Schwammenthal E., et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol 41 (2003) 765-770
169. Romano M.A., and Bolling S.F. Update on mitral repair in dilated cardiomyopathy. J Cardiovasc Surg 19 (2004) 396-400
170. Wu A.H., Aaronson K.D., Bolling S.F., et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45 (2005) 381-387
171. Mehra M.R., and Griffith B.P. Is mitral regurgitation a viable treatment target in heart failure?. The plot just thickened. J Am Coll Cardiol 45 (2005) 388-3
172. Krum H. The task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 26 (2005) 2472
173. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (Writing Committee to Update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 12 (2005) e154-e235
174. Levine R.A., and Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts.
175. Miller D.C. Ischemic mitral regurgitation redux-to repair or to replace?. J Thorac Cardiovasc Surg 122 (2001) 1059
176. Connolly M.W., Gelbfish J.S., Jacobowitz I.J., et al. Surgical results for mitral regurgitation from coronary artery disease. J Thorac Cardiovasc Surg 91 (1986) 379-388
177. Grigioni F., Enriquez-Sarano M., Zehr K.J., et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103 (2001) 1759-1764
178. Iung B. Management of ischemic mitral regurgitation. Heart 89 (2003) 459-464
179. Bursi F., Enriquez-Sarano M., Nkomo V.T., et al. Heart failure and death after myocardial infarction in the community the emerging role of mitral regurgitation. Circulation 111 (2005) 295-301
180. Levine R.A. Dynamic mitral regurgitation-more than meets the eye. N Engl J Med 351 (2004) 1681-1684
181. Lebrun F., Lancellotti P., and Piérard L.A. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. J Am Coll Cardiol 38 (2001) 1685-1692
182. Lancellotti P., Troisfontaines P., Toussaint A.C., et al. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 108 (2003) 1713-1717
183. Tavakoli R., Weber A., Vogt P., et al. Surgical management of acute mitral valve regurgitation due to post-infarction papillary muscle rupture. J Heart Valve Dis 11 1 (2002) 20-25
184. Toils Jr. G.A., Karols D.P., Kopf G.S., et al. Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation. Ann Thorac Surg 74 (2002) 1476-1480
185. Kim Y.H., Czer L.S., Soukiasian H.J., et al. Ischemic mitral regurgitation: Revascularization alone versus revascularization and mitral valve repair. Ann Thorac Surg 79 (2005) 1895-2001
186. Campwala S.Z., Bansal R.C., Wang N., et al. Factors affecting regression of mitral regurgitation following isolated coronary artery bypass surgery. Eur J Cardiothorac Surg 28 (2005) 104-108
187. Gillinov A.M., Wierup P.N., Blackstone E.H., et al. Is repair preferable to replacement for ischemic mitral regurgitation?. J Thorac Cardiovasc Surg 122 (2001) 1125-1141
188. Gillinov A.M., Faber C., Houghtaling P.L., et al. Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. J Thorac Cardiovasc Surg 125 6 (2003) 1350-1362
189. Braun J., Bax J.J., Versteegh M.I., et al. Preoperative left ventricular dimensions predict reverse remodelling following restrictive mitral annuloplasty in ischaemic mitral regurgitation. Eur J Cardiothorac Surg 27 (2005) 847-853
190. Lam B.K., Gillinov A.M., Blackstone E.H., et al. Importance of moderate ischemic mitral regurgitation. Ann Thorac Surg 79 2 (2005) 462-470
191. Prifti E., Bonacchi M., Frati G., et al. Should mild-to-moderate and moderate ischemic mitral regurgitation be corrected in patients with impaired left ventricular function undergoing simultaneous coronary revascularization?. J Cardiovasc Surg 16 6 (2001) 473-483